This inventor holds 9 USPTO granted patents and 5 EPO patents. Top assignee: Friedrich Miescher Institute for Biomedical Research. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Dominik Hartl: Innovator in Nucleic Acid Technology
Introduction: Dominik Hartl, based in Birsfelden, Switzerland, is a notable inventor recognized for his contributions to the field of biotechnology. With a remarkable portfolio of nine patents, he has made significant strides in the development of nucleic acid molecules that hold promise for advancements in gene expression, particularly in rod photoreceptors.
Latest Patents: Among his latest innovations are two significant patents that focus on expression cassettes and promoters essential for gene expression. The first patent describes an expression cassette that includes a SynP160 promoter, which offers an isolated nucleic acid molecule specific for expressing a gene in rod photoreceptors when linked to the appropriate coding sequence. His second patent, titled SYNP161, outlines a promoter for gene expression, similarly targeting rod photoreceptors, demonstrating a sequence with at least 80% identity to a defined nucleic acid sequence.
Career Highlights: Dominik is currently associated with the Friedrich Miescher Institute for Biomedical Research, where his groundbreaking work continues to push the boundaries of genetic research and technology. His expertise in molecular biology has positioned him as a key figure in the development of innovative solutions for genetic expression.
Collaborations: Throughout his career, Dominik has collaborated with several notable colleagues, including Josephine Juettner and Arnaud Krebs. Their combined efforts enhance the research output and foster an environment of innovation and creativity within their projects.
Conclusion: Dominik Hartl stands out as a significant contributor to the world of biotechnology through his extensive patent portfolio. His innovative work at the Friedrich Miescher Institute for Biomedical Research not only showcases his individual talent but also emphasizes the collaborative spirit of scientific inquiry, marking him as an inventor of considerable importance in the realm of nucleic acid technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile